Intangible Capital Rising, IP Key For Start-Ups, Traditional Growth Model Has To Change, Panellists Say 08/11/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The importance of intangible capital is growing and so is the significance of intellectual property, according to some, and in particular in the new economy. Start-ups see intellectual property as an indispensable tool to attract investors and put their innovations onto the market. Developing countries still mainly stuck in what some call the “commodity trap” have to identify and exploit their intellectual property assets, according to panellists at an event held at the World Trade Organization yesterday.
“Peace Has Broken Out” In Software Development, Heralding Open Source As The Future 07/11/2018 by David Branigan, Intellectual Property Watch Leave a Comment “Peace has broken out” between big technology companies and the free and open source software (FOSS) community, according to a leading FOSS advocate, leading a tech industry representative to say, “this is the future.”
USPTO Names Silicon Valley Tech Attorney As New Deputy Director 06/11/2018 by Intellectual Property Watch Leave a Comment The United States Patent and Trademark Office (USPTO) today announced a new deputy director, Laura Peter, a veteran intellectual property attorney, most recently at Silicon Valley cyber-defence firm A10 Networks.
New EU Directive Limits Hate Speech, Establishes European Content Quotas 06/11/2018 by William New, Intellectual Property Watch Leave a Comment A new directive adopted today by European Union member governments updates and strengthens regulations on video-sharing platforms and other newer forms of media, emphasising the public interest, elevating protections for children, and establishing a 30 percent quota of European content in on-demand audiovisual media services.
Report Finds “Overpatenting”, Overpricing Of Top Diabetes Drug In US 05/11/2018 by David Branigan, Intellectual Property Watch 1 Comment Non-profit patent researchers studying the most prominent prescription insulin drug to treat diabetes in the United States found it is “overpatented” and “overpriced,” enabling unwarranted price-hikes resulting in rising costs for patients and taxpayers.
USPTO Solicitor/Deputy General Counsel Leaves For DC Law Firm 05/11/2018 by Intellectual Property Watch Leave a Comment Nathan Kelley has stepped down from his role as solicitor and deputy general counsel at the United States Patent and Trademark Office (USPTO) to join the Perkins Coie law firm in Washington, DC. Kelley also had served as chief administrative patent judge in charge of the Patent Trial and Appeal Board (PTAB).
WTO TRIPS Council Agenda: IP Key For New Businesses, Competition Law To Counter Abuses 05/11/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment World Trade Organization intellectual property committee members gather this week for their annual autumn session. On the agenda are now-usual topics looking at intellectual property from two perspectives: IP as an indispensable tool for innovation in particular in the new economy, and IP as a potential threat to access if misused. In addition, India has put forward further questions on goods in transit to the European Union in its directive on custom enforcement of IP rights.
El mecanismo mundial multilateral de participación en los beneficios: ¿Dónde será el Bretton Woods del Siglo XXI? 05/11/2018 by Intellectual Property Watch 3 Comments Bretton Woods es el nombre de un lugar y también de un sistema. El lugar, Bretton Woods, cuenta con el Hotel Mount Washington y vistas majestuosas de las Montañas Blancas de New Hampshire. El sistema Bretton Woods es el conjunto de normas financieras elaboradas durante una conferencia en dicho hotel que se realizó en julio de 1944 [1]. El sistema creó un orden monetario y permitió la recuperación económica en los años de la posguerra. Para los economistas, Bretton Woods representa al sistema. El éxito del mismo demuestra cómo el pensamiento económico puede penetrar la esfera política y realizar un cambio duradero. John Maynard Keynes, el Darwin de la Economía, encabezó la delegación británica.
No se trata solo de lo material: “El camino a seguir” para el CDB de la ONU, el PN y Half-Earth (mitad de la Tierra) 05/11/2018 by Intellectual Property Watch 1 Comment ¿Es la información “algo” o es “sobre algo”? Esa es esencialmente la pregunta ante la Decimocuarta Conferencia de las Partes (COP) del Convenio de las Naciones Unidas sobre la Diversidad Biológica de 1992 (CBD) que se reunirá del 19 hasta el 27 de noviembre del 2018. La pregunta es de 64 mil millones de dólares. La respuesta podría determinar la modalidad para el “acceso a recursos genéticos“ y una “distribución justa y equitativa de los beneficios” (ABS, por sus siglas en inglés), que es el tercer objetivo plasmado en el CDB. De ser la información transmitida en la vida “algo“ en sí y no “sobre algo”, los beneficios podrían ser mayores por órdenes de magnitud. Dicho de otro modo, los usuarios de recursos genéticos ¿están accediendo a información? o ¿están accediendo a materia, cuyas propiedades están esparcidas entre organismos y jurisdicciones? Si la la respuesta es “información”, se justifica un pago anual de decenas de miles de millones de dólares. En cambio, si la respuesta es “propiedades” justifica las “migajas“que se pagan actualmente.
UAEM: In ‘Historic” Shift, Universities In Canada Adopt Licensing Promoting Access To Medicines 01/11/2018 by Intellectual Property Watch Leave a Comment Universities Allied for Essential Medicines (UAEM) announced today that University of Calgary and McGill University are joining University of British Columbia in adopting Global Access Licensing Principles. These principles promote public access to publicly-funded medicines and life-saving health technologies developed in universities, according to a UAEM press release [pdf].